{"nct_id":"NCT01604889","title":"A Phase 1/2 Randomized, Blinded, Placebo Controlled Study of Ipilimumab in Combination With Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma","status":"TERMINATED","status_verified_date":"2019-03","start_date":"2012-03","start_date_type":"ACTUAL","primary_completion_date":"2016-12-27","primary_completion_date_type":"ACTUAL","completion_date":"2016-12-27","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["INCY"]}